• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹红注射液上市后安全性四种评估方法的比较研究

[Comparative study on four kinds of assessment methods of post-marketing safety of Danhong injection].

作者信息

Li Xuelin, Tang Jinfa, Meng Fei, Li Chunxiao, Xie Yanming

机构信息

The First Affiliated Hospital of Henan College of Pharmacy, Zhengzhou 450000, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2786-8.

PMID:22292365
Abstract

OBJECTIVE

To study the adverse reaction of Danhong injection with four kinds of methods, central monitoring method, chart review method, literature study method and spontaneous reporting method, and to compare the differences between them, explore an appropriate method to carry out post-marketing safety evaluation of traditional Chinese medicine injection.

METHOD

Set down the adverse reactions' questionnaire of four kinds of methods, central monitoring method, chart review method, literature study method and collect the information on adverse reactions in a certain period. Danhong injection adverse reaction information from Henan Province spontaneous reporting system was collected with spontaneous reporting method. Carry on data summary and descriptive analysis.

RESULT

Study the adverse reaction of Danhong injection with four methods of central monitoring method, chart review method, literature study method and spontaneous reporting method, the rates of adverse events were 0.993%, 0.336%, 0.515%, 0.067%, respectively. Cyanosis, arrhythmia, hypotension, sweating, erythema, hemorrhage dermatitis, rash, irritability, bleeding gums, toothache, tinnitus, asthma, elevated aminotransferases, constipation, pain are new discovered adverse reactions.

CONCLUSION

The central monitoring method is the appropriate method to carry out post-marketing safety evaluation of traditional Chinese medicine injection, which could objectively reflect the real world of clinical usage.

摘要

目的

采用集中监测法、病历回顾法、文献研究法和自发报告法四种方法研究丹红注射液的不良反应,比较四种方法的差异,探索适合开展中药注射剂上市后安全性评价的方法。

方法

制定集中监测法、病历回顾法、文献研究法四种方法的不良反应调查问卷,收集一定时期内的不良反应信息。采用自发报告法收集河南省自发报告系统中的丹红注射液不良反应信息。进行数据汇总和描述性分析。

结果

采用集中监测法、病历回顾法、文献研究法和自发报告法四种方法研究丹红注射液的不良反应,不良事件发生率分别为0.993%、0.336%、0.515%、0.067%。发绀、心律失常、低血压、出汗、红斑、出血性皮炎、皮疹、烦躁、牙龈出血、牙痛、耳鸣、哮喘、转氨酶升高、便秘、疼痛等为新发现的不良反应。

结论

集中监测法是开展中药注射剂上市后安全性评价的适宜方法,能客观反映临床使用的真实情况。

相似文献

1
[Comparative study on four kinds of assessment methods of post-marketing safety of Danhong injection].丹红注射液上市后安全性四种评估方法的比较研究
Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2786-8.
2
[Study on 10 409 cases of post-marketing safety Danhong injection centralized monitoring of hospital].10409例丹红注射液上市后医院集中监测安全性研究
Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2783-5.
3
[Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].[中药注射剂上市后安全性监测中应用药物警戒的必要性]
Zhongguo Zhong Yao Za Zhi. 2008 Mar;33(5):612-4.
4
[Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world].基于医院信息系统(HIS)数据库的中成药上市后安全性再评价的真实世界探索方法
Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2779-82.
5
[Study on method on post-marketing traditonal Chinese medicine safety assessment].[中药上市后安全性评价方法研究]
Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2771-5.
6
[Analysis of clinical use of Danhong injection based on hospital information system].基于医院信息系统的丹红注射液临床应用分析
Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2817-20.
7
[Phase 0 clinical trials and post-marketed re-evaluation of clinical safety in injection of traditional Chinese medicine].[中药注射剂0期临床试验与上市后临床安全性再评价]
Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2874-6.
8
[Post-marketed re-evaluation of fleabane injection and Dengzhan Shengmai capsule study on treatment in patients with ischemic stroke].[灯盏细辛注射液与灯盏生脉胶囊治疗缺血性脑卒中患者的上市后再评价研究]
Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2789-92.
9
[A discussion of key issues on postmarketing reevaluation of Chinese medicine].[关于中药上市后再评价关键问题的探讨]
Zhongguo Zhong Yao Za Zhi. 2010 Jun;35(11):1494-7.
10
[Establishment of model of traditional Chinese medicine injections post-marketing safety monitoring].[中药注射剂上市后安全性监测模型的建立]
Zhongguo Zhong Yao Za Zhi. 2013 Sep;38(18):2974-8.

引用本文的文献

1
Postmarketing Safety Surveillance and Reevaluation of Danhong Injection: Clinical Study of 30888 Cases.丹红注射液上市后安全性监测与再评价:30888例临床研究
Evid Based Complement Alternat Med. 2015;2015:610846. doi: 10.1155/2015/610846. Epub 2015 Oct 5.